Company news

Sartorius AG news in 2026

Sartorius AG's news releases, calls and decks from 2026, newest first.

View company

Sartorius maintains positive momentum and continues to grow profitably

July 23, 2026

Sartorius opens new competence center for cell and gene therapy components in Freiburg, Germany

May 21, 2026

Sartorius completes placement of bond with a volume of 500 million euros

May 6, 2026

Sartorius AG Supervisory Board extends appointment of board member Florian Funck

April 24, 2026

Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin

April 23, 2026

Sartorius AG Supervisory Board Extends Appointment of Board Member Rene Faber

March 26, 2026

Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets

March 17, 2026

Sartorius Launches Next-generation Platform to Boost Efficiency in Cell Therapy Production

March 16, 2026

Sartorius Releases Annual Report for 2025

February 16, 2026

Sartorius Sharpens Climate Targets and Receives Validation from Science Based Targets Initiative

February 16, 2026

The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share

February 6, 2026

BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration

February 5, 2026

Sartorius achieves considerable profitable growth in 2025 and maintains positive outlook

February 3, 2026

Sartorius Expands Bio-Circular Product Offering for More Sustainable Bioprocesses

January 14, 2026

Calls in 2026

Decks in 2026